Therapeutic Drug Monitoring Global Market Report 2024

Description

“Therapeutic Drug Monitoring Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic drug monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic drug monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The therapeutic drug monitoring market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Consumables; Equipment; Immunoassay Analyzers; Chromatography And Detectors
2) By Technology: Immunoassays; Chemiluminescence Immunoassays; Chemiluminescence Immunoassays; Colorimetric Immunoassays; Fluorescence Immunoassays; Radioimmunoassay; Other Immunoassays; Chromatography-Ms; Lc-Ms; Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs; Antibiotic Drugs; Immunosuppressant Drugs; Antiarrhythmic Drugs; Bronchodilator Drugs; Psychoactive Drugs; Other Drugs
4) By End-user: Hospital Laboratories; Commercial and Private Laboratories; Other End Users
Companies Mentioned: Abbott Laboratories Inc.; F. Hoffmann-La Roche AG; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Sekisui Medical Co.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Therapeutic drug monitoring (TDM) is a clinical procedure that involves continuous monitoring of a patient's bloodstream to assess the concentration of a specific medicine, ensuring the effectiveness of their dose regimens. TDM is employed for pharmaceuticals that have challenging target concentrations to monitor, medications exhibiting significant pharmacokinetic variability, drugs with established therapeutic effects and notable side effects, and medications with narrow therapeutic ranges.

The primary product types within therapeutic drug monitoring encompass consumables, equipment, immunoassay analyzers, chromatography, and detectors. Consumables for therapeutic drug monitoring include reagents and supplies utilized alongside TDM assays. Various technologies are employed, such as immunoassays, chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassay, other immunoassays, chromatography-ms, lc-ms, and gc-mc. These technologies cover different drug classes, including antiseptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive drugs, and other drugs. Therapeutic drug monitoring is applicable in diverse settings, including hospital laboratories, commercial and private laboratories, and other end-users.

The therapeutic drug monitoring market research report is one of a series of new reports from The Business Research Company that provides therapeutic drug monitoring optical components market statistics, including therapeutic drug monitoring optical components industry global market size, regional shares, competitors with a therapeutic drug monitoring optical components market share, detailed therapeutic drug monitoring optical components market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic drug monitoring optical components industry. This therapeutic drug monitoring optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic drug monitoring market size has grown strongly in recent years. It will grow from $2.1 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historical period can be ascribed to an increasing prevalence of chronic diseases, concerns related to drug safety, integration of pharmacogenomics, a rise in drug development activities, and regulatory emphasis on precision medicine.

The therapeutic drug monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The anticipated growth in the forecast period can be attributed to the increasing applications in oncology, the surge in personalized medicine practices, the global rise in the aging population, the expanded use of point-of-care testing, and the growing expenditure on pharmaceutical research and development. Major trends expected in the forecast period encompass personalized medicine, technological advancements, increased drug development and utilization, point-of-care testing (POCT), and the emergence of biomarkers and assay technologies.

The growth of the therapeutic drug monitoring market is expected to be propelled by the increasing prevalence of organ transplant surgeries. Organ transplantation involves the surgical transfer of an organ from a donor to a recipient. Therapeutic drug monitoring (TDM) of immunosuppressive medications has proven effective in managing patients undergoing solid organ transplantation. Optimizing TDM may help avoid toxic or insufficiently low-dose therapy, which could lead to organ rejection. For example, a January 2023 article from the United Network for Organ Sharing, a non-profit organization managing organ transplants in the US, reported a 3.7% increase in organ transplants in 2022 compared to 2021, totaling 42,887 procedures. Hence, the surge in organ transplant surgeries is a driving factor for the therapeutic drug monitoring market.

The anticipated growth of the therapeutic drug monitoring market is also attributed to the increasing consumption of drugs. Drugs, substances used for medical purposes to diagnose, treat, or prevent diseases in humans or animals, are subject to therapeutic drug monitoring to optimize dosage regimens. This involves measuring and adjusting drug concentrations in the bloodstream to ensure efficacy while minimizing side effects. According to the United Nations Office on Drugs and Crime in June 2023, the global estimate of people who inject drugs was 13.2 million in 2021, marking an 18% increase from previous estimates. Additionally, the global drug usage estimate was over 296 million people in 2021, showing a 23% increase over the previous decade. Therefore, the rising consumption of drugs is a key driver for the therapeutic drug monitoring market.

Product innovations represent a prominent trend gaining traction in the therapeutic drug monitoring market. Leading companies within this sector are dedicated to creating novel products to cater to customer needs and fortify their positions in the market. In October 2021, Promise Proteomics, a proteomics company based in France, introduced mAbXmise kits-a proprietary solution that integrates labeled monoclonal antibodies, reagents, and laboratory supplies for quantifying therapeutic monoclonal antibodies through mass spectrometry. This multiplexing technique surpasses previous analytical methods, offering scientific, clinical, and economic perspectives that thoroughly meet the demands of routine therapeutic drug monitoring.

Prominent companies in the therapeutic drug monitoring market are directing their efforts toward developing testing solutions, including Point-of-Care Testing (POCT) solutions, to address the need for prompt decision-making. Point-of-Care Testing (POCT) involves a medical diagnostic approach that enables rapid testing and analysis of patient samples. For example, in May 2022, THERADIAG, a French company specializing in biological diagnostic tools, unveiled ez-Track1, a Point-of-Care Testing (POCT) solution tailored for therapeutic drug monitoring. This addresses the escalating demand for patient-centric diagnostics in the global healthcare sector. Initially launched in Europe, ez-Track1 conducts tests with whole blood samples, yielding results within 10 minutes and facilitating swift decision-making in implementing biotherapies. The CE-marked system's initial menu includes tests for Infliximab, anti-Infliximab, Adalimumab, and anti-adalimumab, with plans to expand rapidly to cover a broader range of chronic inflammatory diseases and other conditions.

In February 2023, Sentinel Diagnostics, an Italian in vitro diagnostic company, completed the acquisition of Eureka S.r.l. for an undisclosed amount. This strategic move positions Sentinel Diagnostics to emerge as a significant producer and developer of IVD tests. The expanded capabilities resulting from this acquisition will empower Sentinel Diagnostics to offer clinical laboratories a broader selection of assays, spanning from high-throughput core lab tests to the most cutting-edge, specialized second-level assays. EUREKA S.r.l. is an Italian IVD chromatographic company providing ready-to-use diagnostic kits for HPLC, GC, GC-MS, and LC-MS/MS applications, serving special clinical chemistry, therapeutic drug monitoring, occupational toxicology, and forensic toxicology purposes.

Major companies operating in the therapeutic drug monitoring market report are Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMerieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, OraSure Technologies Inc., BioChem Pharmaceuticals, Beckman Coulter Inc., BioTelemetry Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

North America was the largest region in the therapeutic drug monitoring market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the therapeutic drug monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The therapeutic drug monitoring market includes revenues earned by entities by providing drug monitoring, urine drug testing, drug efficacy testing, and drug toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic drug monitoring market also includes sales of Immunoassay kits, Mass spectrometry instruments, and Chromatography systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12149

1. Executive Summary

2. Therapeutic Drug Monitoring Market Characteristics

3. Therapeutic Drug Monitoring Market Trends And Strategies

4. Therapeutic Drug Monitoring Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Therapeutic Drug Monitoring Market Size and Growth

5.1. Global Therapeutic Drug Monitoring Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Therapeutic Drug Monitoring Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Therapeutic Drug Monitoring Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Therapeutic Drug Monitoring Market Segmentation

6.1. Global Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consumables
Equipment
Immunoassay Analyzers
Chromatography And Detectors
6.2. Global Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immunoassays
Chemiluminescence Immunoassays
Colorimetric Immunoassays
Fluorescence Immunoassays
Radioimmunoassay
Other Immunoassays
Chromatography-Ms
Lc-Ms
Gc-Ms
6.3. Global Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antiepileptic Drugs
Antibiotic Drugs
Immunosuppressant Drugs
Antiarrhythmic Drugs
Bronchodilator Drugs
Psychoactive Drugs
Other Drugs
6.4. Global Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Laboratories
Commercial and Private Laboratories
Other End Users

7. Therapeutic Drug Monitoring Market Regional And Country Analysis

7.1. Global Therapeutic Drug Monitoring Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Therapeutic Drug Monitoring Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Therapeutic Drug Monitoring Market

8.1. Asia-Pacific Therapeutic Drug Monitoring Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Therapeutic Drug Monitoring Market

9.1. China Therapeutic Drug Monitoring Market Overview
9.2. China Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Therapeutic Drug Monitoring Market

10.1. India Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Therapeutic Drug Monitoring Market

11.1. Japan Therapeutic Drug Monitoring Market Overview
11.2. Japan Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Therapeutic Drug Monitoring Market

12.1. Australia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Therapeutic Drug Monitoring Market

13.1. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Therapeutic Drug Monitoring Market

14.1. South Korea Therapeutic Drug Monitoring Market Overview
14.2. South Korea Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Therapeutic Drug Monitoring Market

15.1. Western Europe Therapeutic Drug Monitoring Market Overview
15.2. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Therapeutic Drug Monitoring Market

16.1. UK Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Therapeutic Drug Monitoring Market

17.1. Germany Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Therapeutic Drug Monitoring Market

18.1. France Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Therapeutic Drug Monitoring Market

19.1. Italy Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Therapeutic Drug Monitoring Market

20.1. Spain Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Therapeutic Drug Monitoring Market

21.1. Eastern Europe Therapeutic Drug Monitoring Market Overview
21.2. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Therapeutic Drug Monitoring Market

22.1. Russia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Therapeutic Drug Monitoring Market

23.1. North America Therapeutic Drug Monitoring Market Overview
23.2. North America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Therapeutic Drug Monitoring Market

24.1. USA Therapeutic Drug Monitoring Market Overview
24.2. USA Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Therapeutic Drug Monitoring Market

25.1. Canada Therapeutic Drug Monitoring Market Overview
25.2. Canada Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Therapeutic Drug Monitoring Market

26.1. South America Therapeutic Drug Monitoring Market Overview
26.2. South America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Therapeutic Drug Monitoring Market

27.1. Brazil Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Therapeutic Drug Monitoring Market

28.1. Middle East Therapeutic Drug Monitoring Market Overview
28.2. Middle East Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Therapeutic Drug Monitoring Market

29.1. Africa Therapeutic Drug Monitoring Market Overview
29.2. Africa Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Therapeutic Drug Monitoring Market Competitive Landscape And Company Profiles

30.1. Therapeutic Drug Monitoring Market Competitive Landscape
30.2. Therapeutic Drug Monitoring Market Company Profiles
- 30.2.1. Abbott Laboratories Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Siemens Healthineers AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Thermo Fisher Scientific Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sekisui Medical Co.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Therapeutic Drug Monitoring Market Competitive Benchmarking

32. Global Therapeutic Drug Monitoring Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Drug Monitoring Market

34. Therapeutic Drug Monitoring Market Future Outlook and Potential Analysis

34.1 Therapeutic Drug Monitoring Market In 2028 - Countries Offering Most New Opportunities
34.2 Therapeutic Drug Monitoring Market In 2028 - Segments Offering Most New Opportunities
34.3 Therapeutic Drug Monitoring Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer